Showing 3061-3070 of 4169 results for "".
- Dermatologists React to Threat of Coronavirus Pandemichttps://modernaesthetics.com/news/dermatologists-react-to-threat-of-coronavirus-pandemic-1/2472891/Reports about COVID-19 are causing many dermatologists and aesthetic physicians to rethink their travel plans and update their office policy on the care of sick patients. The International Health Regulations Emergency Committee of the World Health Organization declared the outbreak a &l
- Galderma Launches New Collab and Consumer-Facing Rewards Apphttps://modernaesthetics.com/news/galderma-launches-new-collab-and-consumer-facing-rewards-app/2472889/Galderma is enhancing its aesthetic portfolio with digital enhancements to Aspire Galderma Rewards, an expansion of its U.S. salesforce plus a collaboration with ZO Skin Health. "We want to enable every customer and partner to build experiences on our leading platforms,&q
- Get Ready for Allergan's New DTC Juvéderm Lips Campaignhttps://modernaesthetics.com/news/get-ready-for-allergans-new-dtc-juvederm-lips-campaign/2472882/Allergan is launching its new direct-to-consumer campaign for Juvéderm lips with ads and creative deploying across TV, social media, and digital advertising. As part of the new campaign, New York City-based facial plastic surgeon Dara Liotta, MD, reality television personality Au
- Crown Aesthetics Adds ProGen PRP Advantage to Portfoliohttps://modernaesthetics.com/news/crown-aesthetics-adds-progen-prp-advantage-to-portfolio/2472870/ProGen PRP Advantage, an easy-to-use, single-spin system that features 15ml and 30ml tubes, yielding 7-15ml of 2x concentration PRP, is now available from Crown Aesthetics, a division of Crown Laboratories, Inc. With the launch of
- Credentials Over Cost: AAFPRS Issues Warning to Consumers about Discount Cosmetic Treatmentshttps://modernaesthetics.com/news/credentials-over-cost-aafprs-issues-warning-to-consumers-about-discount-cosmetic-treatments/2472867/When promoting your practice, remind potential patients about your credentials and why they must choose a doctor based on his/her training and experience and not simply the best price. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has issued a war
- Crown Laboratories Restructures after Acquisitionshttps://modernaesthetics.com/news/crown-laboratories-restructures-after-acquisitions/2472866/Crown Laboratories has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown says it has been dedicated to transforming its Northeast Tennessee operations into a global skinc
- Revian: USPTO Grants Patent for Biostimulatory Approachhttps://modernaesthetics.com/news/regina-uspto-grants-patent-for-biostimulatory-approach/2472862/The United States Patent and Trademark Office (USPTO) has awarded to Revian Inc. U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the use
- Lutronic Introduces the Most Powerful Thulium Laser to Receive FDA Clearancehttps://modernaesthetics.com/news/lutronic-introduces-the-most-powerful-thulium-laser-to-receive-fda-clearance/2472852/Lutronic unveiled the new LaseMD ULTRA™ during live patient demonstrations at the Cosmetic Surgery Forum in Nashville, TN. The LaseMD ULTRA offersthe highest available power that allows for fast treatments, customizable for multiple areas. Additionally, the system providesgen
- Cutera Launches Heroes Among Us Programhttps://modernaesthetics.com/news/cutera-launches-heroes-among-us-program/2472851/Cutera is launching its new “Heroes Among Us” program to showcase patients who’ve been positively affected by Cutera technologies. The new program was launched at the Cutera University Clinical
- Business News: Hologic to Offload Cynosure for $205Mhttps://modernaesthetics.com/news/business-news-hologic-to-offload-cynosure-for-205m/2472847/Hologic is selling Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, subject to certain closing adjustments. This is a tenth of the $1.6B that Hologic, a women